The effects of endothelin-1 (ET-1) on P-selectin-mediated leukocyte endothelial interaction were examined in vitro. Adherence of autologous polymorphonuclear leukocytes (PMNs) t o the endothelium was markedly enhanced by endothelial stimulation with either (2 U/mL) thrombin, (1 pmol/L) histamine, or (100 nmol/L) phorbol myristate acetate (PMA). In contrast, ET-1 alone (10 and 100 nmol/L) only slightly increased the number of adhering PMNs. The increased PMN adherence t o thrombin-or histamine-stimulated endothelium, which was blocked by an anti-P-selectin monoclonal antibody, was also significantly attenuated by preincubation of coronary segments with (100 nmol/L) ET-1. We further investigated the mechanism of this antiadherence action of ET-1 on thrombin-stimulated endothelial adhesiveness. Preincubation of coronary segments with a selective ETA receptor antagonist, B W 5 (1 pmol/L), had no effect on ET-1 inhibition of thrombin-induced PMN adher-NDOTHELIN-1 (ET-1) IS A potent vasoconstrictor E peptide discovered in endothelial cells.' The three known forms of endothelin (ie, ET-1 , ET-2, and ET-3) mediate their actions via two distinct receptor subtypes, termed ETA and ETB receptors.*.' ET-1 and ET-2 have equal affinity for the ETA receptor, with ET-3 being much less potent, whereas all three forms are equieffective at the ETB re~eptor.~ Increased plasma concentrations of endothelin were found to occur in myocardial ischemia5 and atherosclerosis: These conditions are also characterized by increased endothelial adhesiveness to inflammatory leukocytes, including polymorphonuclear leukocytes (PMNs) and monocytes.',' P-selectin plays an important proinflammatory role in mediating interactions among leukocytes, platelets, and vascular endothelial cell^.^^'^ P-selectin is normally stored in WeibelPalade bodies located within endothelial cells, as well as in a-granules of platelets.' Once these cells are activated by inflammatory mediators such as thrombin or hydrogen peroxide, P-selectin is rapidly translocated to the cell surface.'' We have recently demonstrated that either endogenously occurring or exogenously administered nitric oxide (NO) sig- ence. In contrast, preincubation with a selective ETB receptor antagonist, 80788 (1 pmol/L) significantly reversed ET-1 inhibition of thrombin-induced PMN adherence, whereas the selective ETB receptor agonist BQ-3020 mimicked the inhibitory action of ET-I on thrombin-induced PMN adherence. Furthermore, (100 pmol/L) N"-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase (NOS) inhibitor, significantly attenuated ET-1 inhibition of thrombin-stimulated PMN adherence. These results suggest that ET-1 may inhibit P-selectin-mediated leukocyte-endothelial interaction via ETB receptor stimulation and subsequent endothelial NO formation. This autocrine effect of ET-1 may be involved in pathophysiologic states such as early atherogenesis by preventing leukocyte-endothelial interaction in constricted blood vessels.
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nificantly attenuates P-selectin expression in these cells. NO also inhibits PMN-endothelial interaction by scavenging superoxide radicals, which promote PMN adherence to the end~thelium.'~ DeCaterina et allh recently reported that NO selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. These studies collectively support the concept that NO exerts an important physiologic role by inhibiting endothelial adhesiveness. This property of NO is associated with inhibition of vascular atherogenesis and protection against myocardial ischemiareperfusion injury.'. '' In the vascular wall, ETA receptors are mainly localized in vascular smooth muscle cells and mediate endothelininduced vasoconstriction, whereas ETB receptors are found on both vascular smooth muscle and endothelial cells. ETB receptors located on endothelial cells induce a modest vasorelaxation via release of endothelium-derived NO (EDN0),'83" while ETB receptors on smooth muscle cells induce vasoconstriction. However, little is presently known regarding effects of ET-1 on leukocyte-endothelial interaction" or the role of endothelial ETB receptors in influencing endothelial adhesiveness.
Accordingly, the aims of the present study were (1) to determine direct effects of ET-1 on P-selectin expression on endothelial cells, and (2) to examine whether ET-1 has any regulatory action against thrombin-or histamine-induced Pselectin expression. We also examined whether the ETB receptor-NO pathway has any effect on P-selectin expression in endothelial cells using a selective ETB receptor agonist and antagonist, as well as an NO synthase (NOS) inhibitor.
Monoclonal antibody (MoAb) PB 1.3 binds to P-selectin and blocks the interaction between P-selectin and its carbohydrate ligands. MoAb PB1.3 is an IgGl MoAb raised against human P-selectin that cross-reacts with cat P-selectinz4 and was kindly provided by Dr J.C. Paulson of the Cytel Corp (San Diego, CA).
Cat neutrophils were isolated by a Percoll-density gradient method from peripheral blood collected in citrate-phosphate-dextrose solution, a procedure that has been previously described.', PMNs were washed with Dulbecco's phosphatebuffered saline (DPBS). PMN preparations obtained by this method were greater than 95% pure by differential counting using a hemocytometer and greater than 95% viable by trypan blue exclusion. The PMN pellet was finally suspended in 2 mL of DPBS, and the number of cells was counted using a hemocytometer.
Immediately after drawing 100 mL of blood for PMN isolation, the cat heart was rapidly excised and placed into warm (37°C) oxygenated KrebsHenseleit (K-H) buffer consisting of (in mmoVL): NaCI, 118; KC1, 4.75; CaClZ, 2.54; KHzP04, 1.19; MgS04, 1.19; NaHCO,, 12.5; and glucose, 10.0. The coronary arteries were carefully removed so as to preserve their endothelium, then cleansed of fat and connective tissue, and cut into segments 2 to 3 mm in length for subsequent studies of PMN-endothelial adherence.
Isolated PMNs were subsequently labeled with a fluorescent dye PKH2-GL (Sigma Immunochemical) according to the method of Yuan and Fleming. 25 One milliliter of the dye diluent was added to a loose cell pellet that contained approximately 10 million PMNs. One milliliter of PKH2-GL dye (4 pmol/L) was added to the cell suspension, mixed, and then incubated for 7 minutes. Two milliliters of DPBS that contained 10% platelet-poor plasma (PPP) was added to stop the labeling reaction, and another 5 mL of PBS was added to the suspension. Cells were then centrifuged at 400g for 10 minutes at room temperature. The supernatant was removed, and the cells were resuspended in 2 mL of DPBS and recounted. This labeling procedure does not affect the normal morphology or function of cat PMNS.~," Isolated cat coronary artery segments were placed with their endothelial surface up in polyethylene culture dishes filled with 3 mL of oxygenated K-H buffer at 37°C.
To determine the direct effects of ET-1 on PMN adherence to cat coronary endothelium and to compare with other agonist-stimulated PMN adherence, coronary segments were incubated with either PBS (vehicle control), thrombin (2 U/mL), PMA (100 nmol/L), or ET-1 (Sigma) (10 and 100 nmoVL) at 37°C for IO minutes without stirring. To determine whether the thrombinmediated PMN adherence to coronary endothelium is P-selectindependent, several vascular segments were treated with the P-selectin-neutralizing MoAb PB 1.3 (Cytel) for 5 minutes after stimulation with thrombin.
Protocol 2. To determine whether ET-I has any effect on agonist-induced PMN-endothelial interaction, coronary segments were first treated with ET-1 (100 nmoVL) for 10 minutes. Subsequently, either thrombin (2 U/mL) or histamine (1 pmoUL) was added to the chamber and coronary segments were coincubated with ET-I in the presence of either thrombin or histamine for an additional IO minutes.
We further determined whether the ETB receptorselective agonist BQ3020 (Calbiochem; 100 nmol/L) can mimic effects of ET-1 on thrombin-induced PMN-endothelial interaction, since the predominant ET receptor on endothelial cells is the ETB subtype. In this study, coronary segments were first treated with BQ3020 (100 nmoVL) for 10 minutes. Subsequently, thrombin (2 U/mL) was added to the chamber, and coronary segments were then coincubated with both BQ3020 and thrombin for an additional 10 minutes.
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We also determined the effects of either a selective ETA or a selective ETB receptor antagonist (ie, BQ485 and BQ788; Calbiochem) on ET-I effects on thrombin-induced PMN-endothelial interaction. In these studies, coronary segments were first treated with either BQ485 or BQ788 for 10 minutes. Subsequently, ET-1 was added and coincubated with vascular segments and either of the selective ET receptor antagonists for an additional 10 minutes. After this incubation, thrombin was further incubated for 10 minutes.
Because endothelial ETB receptor stimulation has been shown to elicit endothelial nitric oxide release, we also investigated the effects of the NOS inhibitor, L-NAME (100 pmoVL) on the ET-I -mediated alteration of thrombin-induced PMN-endothelial interaction. In these studies, coronary segments were first treated with L-NAME for IO minutes. Subsequently, ET-1 was added and coincubated vascular segments with L-NAME for an additional 10 minutes. After this incubation, thrombin was further added for 10 minutes.
After these incubations using one of the protocols described, coronary segments were rapidly removed and placed into another culture dish filled with freshly oxygenated K-H solution, and incubated with labeled autologous PMNs (400,000 cells/mL) for an additional 20 minutes. During this period, the culture dishes were agitated in a metabolic shaker bath at 37°C to simulate normal shear forces. After this final incubation, coronary segments were removed, placed onto glass slides, and covered with a coverslip. Labeled PMNs that adhered to the endothelial surface were counted using epifluorescence microscopy (Nikon Diaphot; Nikon, Garden City, NY). Adherent neutrophils on five regions of each vessel segment were randomly counted and expressed as the mean number of PMNs adhering per square millimeter of endothelial surface area."
To clarify effects of ET-1 on endothelial P-selectin expression in cat vessels, coronary rings were isolated from an additional two control cats. Rings were incubated with either PBS, thrombin (2 U/mL), ET-1 (100 nmoUL), ET-I + thrombin, BQ485 + ET-1 + thrombin, or BQ788 + ET-1 + thrombin using the same protocol as in the PMN adherence assay described earlier. Vascular rings were then placed into 4% paraformaldehyde in PBS at 4°C and the rings were fixed for 2 hours on ice. After dehydration, using a series of graded acetone concentrations, rings were embedded in plastic-embedding solution (Polysciences, Wamngton, PA), and 4 pm-thick sections from the tissue blocks were prepared by a glass-cutting microtome.
Immunohistochemical procedures with these plastic sections were performed using the methods of Beckstead et al.z6 Sections were first treated with the primary anti-P-selectin monoclonal antibody PB1.3 overnight at room temperature at a dilution of 1:100, followed by the avidin-biotin immunoperoxidase technique (Vectastain ABC Reagent; Vector Laboratory, Burlingame, CA). The sections were counterstained with Gill's Hematoxylin 3 (Sigma), and examined using a Zeiss Axioplan microscope (Zeiss, New York, NY). MoAb PB 1.3 avidly cross-reacts with feline endothelial ~e l l s . '~~*~~~~ All values presented are the mean 2 SEM, based on the number of independent experiments. All data were subjected to analysis of variance (ANOVA) followed by Fisher's exact test for evaluation of the difference between groups. Probabilities of .05 or less were considered to be statistically significantly different between groups. The procedures used in the present study are in accordance with the guidelines of The Thomas Jefferson University, Committee on the Use and Care of Experimental Animals.
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Immunohistochemisiry. Weibel-Palade bodies to the cell surface after stimulation with inflammatory mediators, and this surface expression of P-selectin facilitates PMN adherence to the endothelium. We examined the effects of ET-1 on PMN adherence to cat coronary vascular endothelium compared with thrombin and the protein kinase C (PKC) activator PMA. Figure 1 summarizes these results. PMN adherence was markedly enhanced by endothelial stimulation with either (2 U/mL) thrombin or (100 nmol/L) PMA. In contrast, 10 and 100 nmoVL ET-I induced only slightly increased numbers of adhering PMNs onto the coronary endothelium. The increased PMN adherence to the thrombin-stimulated coronary endothelium was significantly attenuated by a specific anti-P-selectin MoAb PB1.3 (20 pg/mL) (P < .Ol). Interestingly, preincubation of vascular segments with ET-1 (100 nmol/L) significantly inhibited subsequent thrombin-stimulated increase of PMN adherence to the coronary endothelium. In four additional experiments, ET-1 was tested in the presence of 1 pmoV L histamine. Histamine (1 pmol/L) alone increased PMN adherence from 23 f 3 to 133 ? 13 PMNs/mmZ of cat coronary endothelial surface area (P < .01). However, 100
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RESULTS
Adherence
nmom ET-1 reduced adherence to 67 ? 12 PMNs/mm2 ( P < .01). This 50% attenuation of adherence was comparable to that induced by ET-1 in the presence of 2 U/mL of thrombin. PB1.3, the MoAb directed against P-selectin, reduced PMN adherence to 25 ? 4 PMNs/mm2 in the presence of histamine (1 pmol/L,) ( P < .01) from histamine alone. Thus, the antiadherence effect of ET-1 is not specific to thrombin (eg, due to thrombin receptor antagonism). When ET-1 was added to coronary artery rings without either thrombin or histamine stimulation, there was no direct effect of ET-I on PMN adherence over the concentration range of 10 to 100 nmol5. Role of ET receptor subtype in the inhibitory action of' ET-1 on thrombin-induced endothelial adhesiveness. We further investigated the mechanism of the inhibitory action of ET-1 on thrombin-mediated PMN-endothelial interaction (ie, endothelial adhesiveness). Preincubation of coronary segments with a selective ETA receptor antagonist, BQ485 (1 pmolk), had no significant effect on ET-1-mediated inhibition of thrombin-induced PMN adherence (Fig 2) . In contrast, preincubation of coronary segments with a selective ETB receptor antagonist, BQ788 (1 ymol/L) significantly reversed the ET-1 -mediated inhibition of thrombin-induced PMN adherence. We further determined whether a selective ETB receptor agonist could mimic the inhibitory action of ET-1 on thrombin-induced PMN adherence. The ETB receptor-selective agonist BQ3020 (100 nmol/L) significantly attenuated subsequent thrombin-induced PMN adherence, further implicating ETB receptors as the relevant receptor subtype responsible for the antiadherence action of ET-1. We further determined the role of endogenous NO released via ETB receptor stimulation in mediating the ET-1 -induced inhibition of thrombin-induced PMN adherence. The NOS inhibitor (100 ,umol/L) L-NAME significantly attenuated ET-1 -mediated inhibition of thrombin-stimulated PMN adherence, suggesting that NO mediates this effect (Fig 2) .
These results suggest that ET-1 inhibits P-selectin-mediated endothelial adhesiveness via ETB receptor stimulation, at least part of which is due to subsequent endothelial NO formation and release.
Immunohistochemical loculizution of P-selectin in isoluted cut coronury urteries. P-selectin localization on cat coronary endothelium was examined by immunohistochemical analysis. There was virtually no staining of P-selectin in tissue treated with the secondary antibody only (Fig 3A) . Incubation of coronary artery rings with ET-I (100 nmol/L) for 10 minutes did not upregulate P-selectin expression on coronary endothelium (Fig 3B) . In contrast, incubation of coronary artery rings with 2 U/mL thrombin for 10 minutes significantly increased immunostaining of P-selectin on coronary endothelium (Fig 3C) . When coronary artery rings For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From were first treated with ET-1 (100 nmol/L) for 10 minutes and subsequently stimulated with thrombin ( 2 U/mL), Pselectin immunostaining was markedly attenuated compared with thrombin stimulation alone (Fig 3D) .
Pretreatment of coronary artery rings with the selective ETA receptor antagonist BQ485 did not affect ET-I -mediated inhibition of thrombin-induced P-selectin expression (Fig 3E) . In contrast, pretreatment of coronary artery segments with either selective ETB receptor antagonist BQ788 reversed ET-1 -mediated inhibition of thrombin-induced Pselectin expression (Fig 3F) . Thus, ET-I appears to inhibit P-selectin upregulation on the vascular endothelium by action of the ETB receptor mediating the release of endothelialderived NO. These data correspond closely with the PMN adherence data, and point toward downregulation of P-selectin as an important component of the antiadherence action of ET-1.
DISCUSSION
After discovery of the novel endothelium-derived vasoconstrictor, endothelin, in 1988,' its role in the regulation of vascular tone has been extensively studied. ET-1 also induces mitosis and proliferation of vascular smooth muscle cells, and thus may play a role in promoting atherosclerosis.** However, the role of endothelin in mediating leukocyte-endothelial cell adherence is poorly understood. This issue is particularly relevant since elevated plasma levels of endothelin have been found in myocardial ischemia: post-coronary angi~plasty,'~ and atherosclerosis,6 and these conditions are characterized by increased endothelial adhesiveness to either leukocytes or platelet^.^-^.^' Leukocyte-endothelial interaction involves a complex interplay among adhesion glycoproteins (ie, selectins, integrins, and immunoglobulin superfamily member^).^' P-selectin is rapidly translocated from its intracellular stores in Weibel-Palade bodies to the endothelial cell surface upon activation by inflammatory mediators such as thrombin, hydrogen peroxide, or histamine.'-" P-selectin promotes rolling of leukocytes, the first step in leukocyte-endothelia1 interaction in acute inflammatory conditions.",32 We have previously shown that neutralization of P-selectin with an MoAb (ie, PB 1.3) protects against neutrophil-induced cardiac injury following myocardial i~chemidreperfusion.~~ In this study, P-selectin upregulation occurred in cat coronary arterial and venular endothelium, and the upregulation of Pselectin coincided with reduced coronary endothelial release of NO, as well as with enhanced adherence of neutrophils to this dysfunctional e n d o t h e l i~m .~~ There are four major findings reported in the present study relevant to the role of ET-1 on leukocyte-endothelium interaction. The first is that short-term incubation (ie, 10 minutes) of coronary artery segments with ET-I exerts only a slight stimulatory effect on PMN adherence to the vascular endothelium. This is in contrast to the marked stimulatory effects of either PMA or thrombin on endothelial adhesiveness. Thus, concentrations of ET-1 that are highly vasoactive exert almost no direct effect on leukocyte adherence. Second, ET-1 preincubation significantly inhibited subsequent thrombinstimulated endothelial adhesiveness. This antiadhesive effect was mainly directed against the action of P-selectin as determined by the anti-P-selectin MoAb PB1.3. Third, this antiadhesive action of ET-I was mimicked by the selective ETB agonist BQ3020, and was significantly inhibited by the ETB receptor antagonist BQ788, but not by the ETA receptor antagonist BQ485. These findings clearly point to the ETB receptor as being the relevant receptor subtype responsible for the antiadhesive effect of ET-1. Fourth, the antiadhesive action of ET-1 was reversed by the NOS inhibitor L-NAME, indicating that endogenous release of NO by ET-I -induced ETB activation mediates this antiadhesive effect. These results suggest that ET-1 has an autocrine action that attenuates endothelial adhesiveness, apparently via ETB receptor-induced release of endothelium-derived NO.
We observed an increased endothelial adhesiveness to thrombin or to histamine that was significantly blocked by the specific anti-P-selectin MoAb PB 1.3. This suggests that ET-1 inhibits thrombin-or histamine-induced P-selectin expression and PMN adherence. This concept was further confirmed by immunohistochemical analysis, in which ET-I was shown to clearly inhibit thrombin-induced P-selectin immunostaining in cat coronary arteries. The ET-I effect was inhibited by the selective ETB receptor antagonist BQ788, but not by the selective ETA receptor antagonist BQ485. Moreover, our data suggest that selective ETB receptor stimulation inhibits endothelial adhesiveness via an NO-dependent mechanism. In this regard, we have recently demonstrated that either endogenous or exogenous NO inhibits P-selectin expression in platelets and endothelial cells in vitro and in vivo."." Furthermore, it is now generally accepted that endothelial ETB receptor stimulation mediates NO release, which may produce a transient vasorelaxation.' However, Kurihara et al" recently demonstrated that ET-1 +/-heterozygous mice show a significant blood pressure increase despite a 50% reduction in plasma concentrations of ET-1. Although the role of endothelial ETB receptors in blood pressure regulation in vivo needs further clarification, ETB receptor-mediated endothelial NO release may play an important role not only in the regulation of vascular tone, but also in other aspects of vascular biology. Recently, two reports have appeared in which direct measurements of NO were tnade in response to ETB receptor stimulation. Stimulation of ETB receptors released NO in endothelial cells,34 as well as in kidney cells.'5 These findings are consistent with the results obtained in the present study. In this regard, the present study demonstrates a significant action of the ETB receptor-NO pathway on leukocyte-endothelia1 interaction for the first time.
The present study does not rule out possible effects of ET-1 on other endothelial adhesion molecules (ie, ICAM-1, VCAM-1). However, there are few studies investigating the effects of ET-1 on specific cell adhesion molecules. McCarron et a136 demonstrated that a 4-hour incubation of ET-I, ET-2, and ET-3 stimulated ICAM-1, VCAM-1, and E-selectin expression in cultured brain microvascular endothelial cells, and surprisingly the degree of expression was equivalent to that stimulated by 100 U/mL tumor necrosis factor-cy. Because the predominant ET receptor subtype on endothelial cells is ETB, and because all three endothelins have equal For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From affinity for the ETB receptor, the effects observed by McCarron et al might also be mediated through the ETB receptor. It is therefore conceivable that long-term incubation of ET-1 may increase endothelial adhesiveness by enhanced expression of Ig superfamily members. In contrast, Farr6 et alZ0 demonstrated that 30 minutes of incubation with ET-I stimulates neutrophil CD18 expression and adhesion to the endothelial surface, and that preincubating endothelial cells alone with ET-1 had no stimulatory effect on neutrophil adherence. Therefore, effects of ET-1 on endothelial expression of ICAM-1 may require a long expression time. The effects of ET-1 on ICAM-1 expression are still uncertain and need further clarification.
In conclusion, we have demonstrated for the first time that short-term ET-1 administration has an inhibitory action against P-selectin-mediated leukocyte-endothelial interaction. Since P-selectin expression occurs within 10 to 20 minutes of inflammatory stimuli (eg, thrombin, histamine) and is sustained for about 60 min~tes,~' there may be a window of opportunity allowing ET-1 to act as a modulator of adhesive interaction between leukocytes and the endothelium. This is consistent with the observation that ET-1 is rapidly released after coronary angi~plasty.~' This inhibitory effect of ET-1 on leukocyte-endothelial interaction appears to be at least in part mediated by stimulating endothelial NO release via the ETB receptor subtype. This autocrine effect of ET-1 may play an important self-protective role in pathophysiologic states such as early atherogenesis by preventing leukocyteendothelial interaction3' in the face of increased vascular tone.
